Disorder of Urinary Stent
Conditions
Brief summary
The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.
Interventions
DRUGTamsulosin
DRUGOxybutynin
Sponsors
Phoenix Children's Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Eligibility
Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Patients aged 4-18 years will be enrolled in this study. We will include all patients who will have a ureteral stent placement after their procedure.
Exclusion criteria
* Patients with developmental delay or unable to verbalize their pain level will be excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of doses of pain in medication used | 5 days post-op | After surgery, each child will be prescribed the standard dosage of oxycodone/acetaminophen based on their weight. We will have the patient's family record the number of doses of narcotics used from post-operative day #1 to post-operative day #5 to assess their pain needs. |
| Pain scale based on the faces pain score | 5 days post-op | We will have the family members record the child's pain score in the morning and evening using the faces pain scale and record the score. |
Outcome results
None listed